LEVOMETHADYL ACETATE (LAAM) FOR THE TREATMENT OF OPIOID DEPENDENCE: A MULTISITE, OPEN-LABEL STUDY OF LAAM SAFETY AND AN EVALUATION OF THE PRODUCT LABELING AND TREATMENT REGULATIONS.
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | |
| פורמט: | ספר |
| שפה: | ספרדית אנגלית |
| נושאים: | |
| גישה מקוונת: | Path Enlace web pago |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים: LEVOMETHADYL ACETATE (LAAM) FOR THE TREATMENT OF OPIOID DEPENDENCE: A MULTISITE, OPEN-LABEL STUDY OF LAAM SAFETY AND AN EVALUATION OF THE PRODUCT LABELING AND TREATMENT REGULATIONS.
- A COMPARISON OF LEVOMETHADYL ACETATE, BUPRENORPHINE, AND METHADONE FOR OPIOID DEPENDENCE
- HIV RISK BEHAVIORS DURING PHARMACOLOGIC TREATMENT FOR OPIOID DEPENDENCE: A COMPARISON OF LEVOMETHADYL ACETATE HYDROCHLORIDE, BUPRENORPHINE, AND METHADONE
- DRUG INTERACTIONS BETWEEN OPIOIDS AND ANTIRETROVIRAL MEDICATIONS: INTERACTION BETWEEN METHADONE, LAAM, AND DELAVIRDINE
- DRUG INTERACTIONS BETWEEN OPIOIDS AND ANTIRETROVIRAL MEDICATIONS: INTERACTION BETWEEN METHADONE, LAAM, AND NELFINAVIR
- LAAM - PHARMACOLOGY AND PHARMACOKINETICS, DEVELOPMENTAL HISTORY, AND THERAPEUTIC CONSIDERATIONS
- RELATIONSHIP BETWEEN LAAM-METHADONE PREFERENCE AND TREATMENT OUTCOMES